269 related articles for article (PubMed ID: 15476279)
1. The prion protein in human neuromuscular diseases.
Kovács GG; Kalev O; Gelpi E; Haberler C; Wanschitz J; Strohschneider M; Molnár MJ; László L; Budka H
J Pathol; 2004 Nov; 204(3):241-7. PubMed ID: 15476279
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
3. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
[TBL] [Abstract][Full Text] [Related]
4. A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages.
De Paepe B; Creus KK; Martin JJ; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():463-9. PubMed ID: 19758187
[TBL] [Abstract][Full Text] [Related]
5. [Significance of rimmed vacuoles in neuromuscular disorders--a comparative immunohistochemical study of inclusion body myositis and distal myopathy with rimmed vacuole formation].
Murakami N; Takemitsu M; Kurashige T; Nonaka I
Rinsho Shinkeigaku; 1994 Aug; 34(8):782-7. PubMed ID: 7994984
[TBL] [Abstract][Full Text] [Related]
6. Expression of the intermediate filament protein synemin in myofibrillar myopathies and other muscle diseases.
Olivé M; Goldfarb L; Dagvadorj A; Sambuughin N; Paulin D; Li Z; Goudeau B; Vicart P; Ferrer I
Acta Neuropathol; 2003 Jul; 106(1):1-7. PubMed ID: 12669240
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.
Zanusso G; Vattemi G; Ferrari S; Tabaton M; Pecini E; Cavallaro T; Tomelleri G; Filosto M; Tonin P; Nardelli E; Rizzuto N; Monaco S
Brain Pathol; 2001 Apr; 11(2):182-9. PubMed ID: 11303793
[TBL] [Abstract][Full Text] [Related]
8. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis.
Kumamoto T; Ueyama H; Tsumura H; Toyoshima I; Tsuda T
Acta Neuropathol; 2004 Jan; 107(1):59-65. PubMed ID: 14513262
[TBL] [Abstract][Full Text] [Related]
9. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
Greenberg SA; Pinkus JL; Amato AA
Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
11. Congenital myopathy with abundant ring fibres, rimmed vacuoles and inclusion body myositis-type inclusions.
Fidziańska A; Kamińska A
Neuropediatrics; 2003 Feb; 34(1):40-4. PubMed ID: 12690567
[TBL] [Abstract][Full Text] [Related]
12. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
[TBL] [Abstract][Full Text] [Related]
13. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
[TBL] [Abstract][Full Text] [Related]
14. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy.
Haslbeck KM; Friess U; Schleicher ED; Bierhaus A; Nawroth PP; Kirchner A; Pauli E; Neundörfer B; Heuss D
Acta Neuropathol; 2005 Sep; 110(3):247-54. PubMed ID: 15986224
[TBL] [Abstract][Full Text] [Related]
15. The pathological diagnosis of specific inflammatory myopathies.
Carpenter S; Karpati G
Brain Pathol; 1992 Jan; 2(1):13-9. PubMed ID: 1341942
[TBL] [Abstract][Full Text] [Related]
16. Rimmed vacuoles in facioscapulohumeral muscular dystrophy: a unique ultrastructural feature.
Neudecker S; Krasnianski M; Bahn E; Zierz S
Acta Neuropathol; 2004 Sep; 108(3):257-9. PubMed ID: 15221332
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles.
Tateyama M; Takeda A; Onodera Y; Matsuzaki M; Hasegawa T; Nunomura A; Hirai K; Perry G; Smith MA; Itoyama Y
Acta Neuropathol; 2003 Jun; 105(6):581-5. PubMed ID: 12734664
[TBL] [Abstract][Full Text] [Related]
18. Tenascin is a useful marker in the diagnosis of inflammatory myopathies.
Müller-Felber W; Toepfer M; Müller T; Müller-Höcker J; Fischer P; Lochmüller H; Pongratz D
Eur J Med Res; 1998 Jun; 3(6):281-7. PubMed ID: 9620889
[TBL] [Abstract][Full Text] [Related]
19. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
Sarkozi E; Askanas V; Engel WK
Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
[TBL] [Abstract][Full Text] [Related]
20. [Histological data in inflammatory myositis].
Mikol J; Polivka M
Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
